AIKIDO PHARMA INC (AIKI)       6.23  -0.07 (-1.11%)

6.23  -0.07 (-1.11%)

US0088753043 - Common Stock

AIKIDO PHARMA INC6.23

NASDAQ:AIKI (8/16/2022, 5:17:36 PM)-0.07 (-1.11%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology
Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend
Overview
Earnings (Last) 05-16 2022-05-16/dmh Earnings (Next) 08-23 2022-08-23/amc
Ins Owners N/A Inst Owners 13.66%
Market Cap 32.72M Shares 5.25M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 82.86
IPO 03-18 1980-03-18

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

AIKI Daily chart

Company Profile

Aikido Pharma Inc is a US-based company operating in Biotechnology industry. The company is headquartered in New York City, New York and currently employs 4 full-time employees. AIkido Pharma Inc. is a biotechnology company, with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The Company’s pipeline consists of patented technology from universities and researchers. The firm advances its therapeutic drug pipeline through a collaboration with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). The company is also developing a broad-spectrum antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. Its pancreatic drug candidate, DHA-dFdC, developed at and licensed from the University of Texas at Austin, is a chemotherapy treatment for advanced pancreatic cancer.

Company Info

AIKIDO PHARMA INC

One Rockefeller Plaza, 11Th Floor

New York City NEW YORK 10020

P: 13473217646.0

CEO: Anthony Hayes

Employees: 4

Website: https://aikidopharma.com/

News

News Imagea month ago - AIkido Pharma Inc.AIkido Pharma, Inc. Hires Carlos Aldavero to Lead Financial Services Subsidiary

/PRNewswire/ -- Anthony Hayes, CEO of AIkido Pharma Inc. (NASDAQ: AIKI) ("AIkido" or the "Company"), announced the hiring of Carlos Aldavero as President of...

News Image2 months ago - AIkido Pharma Inc.AIkido Inc. Announces the Formation of a New Financial Services Subsidiary

/PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") announced the formation of a wholly owned subsidiary with the purpose of making...

News Image2 months ago - AIkido Pharma Inc.AIkido Pharma Inc. Appoints New Director, Soo Yu

/PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced the appointment of Ms. Soo Yu, as a director of the Company....

News Image2 months ago - InvestorPlaceNVAX Stock Alert: 14 Things to Know as the Novavax Vaccine Faces the FDA Today

Novavax (NVAX) stock is in the news today as investors prepare for the results from the vaccine company's meeting with the FDA.

News Image2 months ago - InvestorPlaceWhy Is AIkido Pharma (AIKI) Stock Up 1,400%?

AIkido Pharma (AIKI) stock is skyrocketing on Tuesday but it's not due to any positive news from the biotechnology company.

AIKI Twits

Here you can normally see the latest stock twits on AIKI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example